A Systematic Review on the Contribution of Artificial Intelligence in the Development of Medicines for COVID-2019

Background: COVID-2019 pandemic lead to a raised interest on the development of new treatments through Artificial Intelligence (AI). Aim: to carry out a systematic review on the development of repurposed drugs against COVID-2019 through the application of AI. Methods: The Systematic Reviews and Meta...

Descripción completa

Detalles Bibliográficos
Autor principal: Pires, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465965/
https://www.ncbi.nlm.nih.gov/pubmed/34575703
http://dx.doi.org/10.3390/jpm11090926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465965/
https://www.ncbi.nlm.nih.gov/pubmed/34575703
http://dx.doi.org/10.3390/jpm11090926

Ejemplares similares